Leading Technology-Enabled Selling Software Now Available in Kanji Language
ATLANTA, July 16 /PRNewswire/ -- Strengthening its position as a global
provider of pharmaceutical sales force automation (SFA) systems, Sales
Technologies/Walsh, a unit of IMS HEALTH (NYSE: RX), today announced that
Cornerstone(TM), one of Sales Technologies/Walsh's leading products, is now
available in the Kanji language. With this version, named Cornerstone K,
Japanese organizations will have access to the most technically advanced,
flexible and reliable SFA solution currently available to pharmaceutical
companies.
With Cornerstone K, Sales Technologies/Walsh has developed a fully
translatable product, enabling Japanese organizations to take advantage of the
product's inherent functionality to define, create and manage an
enterprise-wide system in the Kanji language. The new version is double-byte
enabled to support languages such as Japanese Kanji. Additionally, through
Cornerstone's configuration layer, the product is localized to address unique
Japanese country-specific business processes.
In order to guarantee the quality of Cornerstone K, the product recently
completed Sales Technologies/Walsh's gold certification testing process to
ensure that the product appropriately addresses regional and cultural
differences. This quality assurance process is standard at Sales
Technologies/Walsh to ensure that all products are ready for customer
deployment.
The Cornerstone K release coincides with recent announcements issued by
Sales Technologies/Walsh and its parent company, IMS HEALTH, of their
strategic initiatives in the Japanese pharmaceutical marketplace. The
Cornerstone K version is enabled for all IMS HEALTH data, including the latest
next-generation market data collection and reporting service that delivers
pharmaceutical market information to its Japan clients on a weekly, rather
than monthly, basis.
"We believe that by building on a solid product foundation, we can further
expand into new markets with a quality product that is flexible enough to
accommodate various market differences," said John Lax, vice president of
development for Cornerstone. "We recognize that as the global provider of the
leading-edge sales automation system, we have an obligation to meet the unique
demands of pharmaceutical markets worldwide."
Sales Technologies/Walsh is the leading global provider of sales force
automation products and services to the pharmaceutical industry. More than
35,000 pharmaceutical executives worldwide depend on Sales Technologies/Walsh
to make business decisions each day. Services include sales force automation
systems, strategic sales and marketing information solutions, and the
provision of client-critical databases. Additional information is available
at http://www.salestech.com.
Sales Technologies/Walsh is a division of IMS HEALTH (NYSE: RX), the
world's leading provider of information solutions to the pharmaceutical and
healthcare industries. With more than $1 billion in 1997 revenue, IMS HEALTH
operates in over 90 countries. IMS HEALTH is the largest pharmaceutical
manufacturer information partner, with over 40 years' experience in the
industry. Key products and services integral to customer day-to-day
operations include: market research for prescription and over-the-counter
pharmaceutical products; sales management information to optimize sales force
productivity; technology enabled selling solutions for sales and marketing
decision-making; and technology systems and information services that support
managed care organizations. Additional information is available at
http://imshealth.com.
SOURCE IMS HEALTH
 back to top
Related links:
http://imshealth.com
Company News On-Call: http://www.prnewswire.com or
fax, 800-758-5804, ext. 115785
CONTACT:
Ken Goodgames of IMS HEALTH, 404-841-4898
|
